NO20020827L - Piperidinalkoholer - Google Patents
PiperidinalkoholerInfo
- Publication number
- NO20020827L NO20020827L NO20020827A NO20020827A NO20020827L NO 20020827 L NO20020827 L NO 20020827L NO 20020827 A NO20020827 A NO 20020827A NO 20020827 A NO20020827 A NO 20020827A NO 20020827 L NO20020827 L NO 20020827L
- Authority
- NO
- Norway
- Prior art keywords
- disease
- disorders
- compulsive
- piperidine alcohol
- psychoses
- Prior art date
Links
- RALRVIPTUXSBPO-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol Chemical compound C=1C=C(Cl)C(C(F)(F)F)=CC=1C1(O)CCNCC1 RALRVIPTUXSBPO-UHFFFAOYSA-N 0.000 title 1
- 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 abstract 1
- 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000032841 Bulimia Diseases 0.000 abstract 1
- 206010006550 Bulimia nervosa Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 206010029333 Neurosis Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 208000015238 neurotic disease Diseases 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19939756A DE19939756A1 (de) | 1999-08-21 | 1999-08-21 | Piperidinalkohole |
| PCT/EP2000/007664 WO2001014332A1 (de) | 1999-08-21 | 2000-08-08 | Piperidinalkohole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20020827D0 NO20020827D0 (no) | 2002-02-20 |
| NO20020827L true NO20020827L (no) | 2002-02-20 |
Family
ID=7919197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020827A NO20020827L (no) | 1999-08-21 | 2002-02-20 | Piperidinalkoholer |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6756370B1 (cs) |
| EP (1) | EP1202966B1 (cs) |
| JP (1) | JP2003507455A (cs) |
| KR (1) | KR20020027502A (cs) |
| CN (1) | CN1170819C (cs) |
| AR (1) | AR025333A1 (cs) |
| AT (1) | ATE268757T1 (cs) |
| AU (1) | AU760392B2 (cs) |
| BR (1) | BR0013467A (cs) |
| CA (1) | CA2382295A1 (cs) |
| CZ (1) | CZ2002499A3 (cs) |
| DE (2) | DE19939756A1 (cs) |
| DK (1) | DK1202966T3 (cs) |
| ES (1) | ES2220537T3 (cs) |
| HU (1) | HUP0203406A2 (cs) |
| MX (1) | MXPA02001750A (cs) |
| NO (1) | NO20020827L (cs) |
| PL (1) | PL353590A1 (cs) |
| PT (1) | PT1202966E (cs) |
| SK (1) | SK2192002A3 (cs) |
| WO (1) | WO2001014332A1 (cs) |
| ZA (1) | ZA200202291B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US7902679B2 (en) * | 2001-03-05 | 2011-03-08 | Megica Corporation | Structure and manufacturing method of a chip scale package with low fabrication cost, fine pitch and high reliability solder bump |
| US20050256131A1 (en) * | 2002-05-24 | 2005-11-17 | Carl-Fr Coester | Pharmaceutical active substance combination and the use thereof |
| SI1831159T1 (sl) * | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Derivati tetralina in indana ter njune uporabe |
| CN101891672B (zh) * | 2010-07-07 | 2012-07-11 | 天津大学 | 哌啶酮加氢反应液提纯哌啶醇产品的分离提纯方法及装置 |
| US20120129834A1 (en) * | 2010-09-17 | 2012-05-24 | Buck Institute For Research On Aging | Serotonin receptor antagonists for use in the treatment of huntington's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA864772B (en) * | 1985-07-02 | 1987-02-25 | Merrell Dow Pharma | Novel chemical compounds |
| US5093341A (en) * | 1987-12-17 | 1992-03-03 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine derivatives useful as antithrombolytic agents |
| HU213271B (en) * | 1990-06-01 | 1997-04-28 | Merrell Dow Pharma | Process for producing (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole and pharmaceutical compositions containing the same |
| NZ249286A (en) * | 1992-02-13 | 1996-02-27 | Merrell Dow Pharma | Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions |
| FR2696744B1 (fr) * | 1992-10-12 | 1994-12-30 | Logeais Labor Jacques | Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique. |
| AU1301497A (en) * | 1995-12-20 | 1997-07-14 | Reinhard Laven | Novel 1-phenylalkyl/alkylene-4-(.alpha.-hydroxydiphenylmethyl)-pip eridine derivatives and their use as serotonin antagonists |
| GB9718712D0 (en) * | 1997-09-03 | 1997-11-12 | Merck Sharp & Dohme | Theraputic Agents |
-
1999
- 1999-08-21 DE DE19939756A patent/DE19939756A1/de not_active Withdrawn
-
2000
- 2000-08-08 CA CA002382295A patent/CA2382295A1/en not_active Abandoned
- 2000-08-08 EP EP00964004A patent/EP1202966B1/de not_active Expired - Lifetime
- 2000-08-08 JP JP2001518422A patent/JP2003507455A/ja active Pending
- 2000-08-08 DE DE50006759T patent/DE50006759D1/de not_active Expired - Fee Related
- 2000-08-08 US US10/069,054 patent/US6756370B1/en not_active Expired - Fee Related
- 2000-08-08 AU AU75088/00A patent/AU760392B2/en not_active Ceased
- 2000-08-08 DK DK00964004T patent/DK1202966T3/da active
- 2000-08-08 BR BR0013467-8A patent/BR0013467A/pt not_active IP Right Cessation
- 2000-08-08 PT PT00964004T patent/PT1202966E/pt unknown
- 2000-08-08 ES ES00964004T patent/ES2220537T3/es not_active Expired - Lifetime
- 2000-08-08 CN CNB00811840XA patent/CN1170819C/zh not_active Expired - Fee Related
- 2000-08-08 KR KR1020027000962A patent/KR20020027502A/ko not_active Withdrawn
- 2000-08-08 SK SK219-2002A patent/SK2192002A3/sk unknown
- 2000-08-08 HU HU0203406A patent/HUP0203406A2/hu unknown
- 2000-08-08 CZ CZ2002499A patent/CZ2002499A3/cs unknown
- 2000-08-08 WO PCT/EP2000/007664 patent/WO2001014332A1/de active IP Right Grant
- 2000-08-08 AT AT00964004T patent/ATE268757T1/de not_active IP Right Cessation
- 2000-08-08 MX MXPA02001750A patent/MXPA02001750A/es unknown
- 2000-08-08 PL PL00353590A patent/PL353590A1/xx unknown
- 2000-08-18 AR ARP000104296A patent/AR025333A1/es not_active Application Discontinuation
-
2002
- 2002-02-20 NO NO20020827A patent/NO20020827L/no not_active Application Discontinuation
- 2002-03-20 ZA ZA200202291A patent/ZA200202291B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200202291B (en) | 2003-10-29 |
| SK2192002A3 (en) | 2002-06-04 |
| PL353590A1 (en) | 2003-12-01 |
| NO20020827D0 (no) | 2002-02-20 |
| JP2003507455A (ja) | 2003-02-25 |
| DK1202966T3 (da) | 2004-09-27 |
| CN1371365A (zh) | 2002-09-25 |
| EP1202966B1 (de) | 2004-06-09 |
| CA2382295A1 (en) | 2001-03-01 |
| CN1170819C (zh) | 2004-10-13 |
| US6756370B1 (en) | 2004-06-29 |
| PT1202966E (pt) | 2004-10-29 |
| MXPA02001750A (es) | 2003-03-27 |
| HUP0203406A2 (hu) | 2003-02-28 |
| ATE268757T1 (de) | 2004-06-15 |
| KR20020027502A (ko) | 2002-04-13 |
| AU760392B2 (en) | 2003-05-15 |
| BR0013467A (pt) | 2002-04-30 |
| CZ2002499A3 (cs) | 2002-05-15 |
| EP1202966A1 (de) | 2002-05-08 |
| DE50006759D1 (de) | 2004-07-15 |
| ES2220537T3 (es) | 2004-12-16 |
| AU7508800A (en) | 2001-03-19 |
| DE19939756A1 (de) | 2001-02-22 |
| WO2001014332A1 (de) | 2001-03-01 |
| AR025333A1 (es) | 2002-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0012607A (pt) | Derivados de n- (indolcarbonil) piperazina | |
| BR0107578A (pt) | Derivados de piperidina e piperazina | |
| TW200503713A (en) | Novel compounds | |
| NO20072283L (no) | Fremgangsmate for fremstilling av annelerte piperazin-2-on derivater samt mellomprodukter i samme | |
| HRP20041042A2 (hr) | Novi supstituirani derivati sulfamata kao antikonvulzivi | |
| AU7335896A (en) | Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same | |
| GB0325956D0 (en) | Novel compounds | |
| TW200503710A (en) | Novel compounds | |
| NO20062656L (no) | Fremgangsmate for fremstilling av statiner | |
| NO20064752L (no) | N-piperidinderivater som CCR3-modulatorer | |
| NO20020827L (no) | Piperidinalkoholer | |
| TW200514781A (en) | Novel compounds | |
| DE602004007658D1 (de) | Indolderivate mit verbesserter antipsychotischer wirkung | |
| BR0012575A (pt) | Derivados de indol | |
| ATE442355T1 (de) | Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung | |
| NZ593279A (en) | Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors | |
| ATE282605T1 (de) | 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie | |
| MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
| CO5640133A2 (es) | Derivados de 4-(2-feniloxifenil)-piperidina o 1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de la serotonina | |
| PL361741A1 (en) | Piperazinylcarbonylquinolines and -isoquinolines | |
| ATE270287T1 (de) | 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme | |
| DE50310200D1 (de) | Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte | |
| MXPA05010678A (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina. | |
| WO2002088143A3 (en) | Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands | |
| BRPI0417147A (pt) | processo para preparação de derivados de (3-oxo-2,3-dihidro-1h-isoindol-1-il)-acetilguanidinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |